Australian Artificial Intelligence Institute

Business leaders from Microsoft, Salesforce and LinkedIn among the speakers at VDS2023

Retrieved on: 
Wednesday, October 4, 2023

As well as serving as a nexus for entrepreneurs, startups, corporations, and investors, VDS2023 will also feature speakers from leading national and international venture capital firms.

Key Points: 
  • As well as serving as a nexus for entrepreneurs, startups, corporations, and investors, VDS2023 will also feature speakers from leading national and international venture capital firms.
  • Valencia Digital Summit 2023 promises to delve deep into the major societal challenges of our era through its carefully curated programme.
  • Embracing the theme of 'Building the Good Future', this summit will bring together global economic and tech leaders to address pressing issues that are shaping the world's path toward a more promising future.
  • The main topics of discussion will be artificial intelligence, mobility, sustainability, longevity, the future of work, and the role of women in tech.

NETA AUTO selects BlackBerry QNX to Power the NETA S, Next-Generation EV Sedan for the Chinese Market

Retrieved on: 
Tuesday, August 2, 2022

As part of the agreement, the NETA S will use the BlackBerry QNX Neutrino RTOS and QNX Hypervisor for the vehicle's new intelligent technology cockpit, the 'NETA SPACE'.

Key Points: 
  • As part of the agreement, the NETA S will use the BlackBerry QNX Neutrino RTOS and QNX Hypervisor for the vehicle's new intelligent technology cockpit, the 'NETA SPACE'.
  • "BlackBerry is pleased to empower China's new energy automotive brands with our latest technologies, helping NETA AUTO to expand its footprint for the future of safe & secure mobility."
  • "In the future, NETA AUTO will continue to collaborate with BlackBerry to bring more convenient, enriched and intelligent automotive life experiences to our customers."
  • The NETA S has a digital design style that fully demonstrates the power and athleticism expected of a sports sedan.

WellPower Partners with Natural Language Processing (NLP) Platform Augintel to Help Clinicians Save Time and Improve Clinical Outcomes

Retrieved on: 
Thursday, July 21, 2022

CHICAGO, July 21, 2022 /PRNewswire-PRWeb/ -- Augintel, an NLP-based SaaS platform that gives clinicians a deeper understanding of the people they care for, today announced that WellPower, Denver's community mental health provider, has selected the Augintel platform to read and process extensive amounts of case notes. The service is designed to help clinicians make well-informed decisions that will lead to improved clinical outcomes.

Key Points: 
  • The service is designed to help clinicians make well-informed decisions that will lead to improved clinical outcomes.
  • Recognized nationally for innovative and effective behavioral health care, WellPower looked for an innovative solution to better access notes and chose Augintel.
  • "Reducing burdens and burnout among our clinical staff is a top priority for us," said Wes Williams, CIO of WellPower.
  • Our nationally-recognized services help children, families and adults in the Denver community create a path to living happier and healthier lives.

Amberstone Biosciences Secures $12 Million Series A Financing to Advance Immuno-Oncology Pipeline of Tumor Microenvironment Activated Therapeutics

Retrieved on: 
Monday, January 3, 2022

Amberstone Biosciences ( www.amberstonebio.com ), an emerging biotherapeutics company with unique expertise in conditionally active immunotherapeutics, today announced the completion of a $12 million Series A financing round.

Key Points: 
  • Amberstone Biosciences ( www.amberstonebio.com ), an emerging biotherapeutics company with unique expertise in conditionally active immunotherapeutics, today announced the completion of a $12 million Series A financing round.
  • Amberstone will use the proceeds from the financing to advance its highly differentiated tumor microenvironment activated therapeutic programs including bispecific antibodies and immunocytokines to the investigational new drug application (IND) enabling stage.
  • We are tremendously grateful for the strong support from our new and existing investors, said Amberstone Biosciences President and CEO, George Wu, PhD.
  • With our unique Tumor Microenvironment Activated Therapeutics (T-MATE) programs, we aim to develop safer and more effective therapies to benefit cancer patients.

Quantum Computing Inc.’s (QCI) Robert Liscouski and Steve Reinhardt to Take Part in Panel Discussions at IEEE Quantum Week’s QCE21

Retrieved on: 
Monday, October 18, 2021

Steve Reinhardt, QCIs VP of product development, is responsible for the creation of quantum ready-to-run software that helps businesses harness the power of quantum computing today; his prior experience includes commercializing cutting-edge technologies into mainstream use at leading computing organizations.

Key Points: 
  • Steve Reinhardt, QCIs VP of product development, is responsible for the creation of quantum ready-to-run software that helps businesses harness the power of quantum computing today; his prior experience includes commercializing cutting-edge technologies into mainstream use at leading computing organizations.
  • Mr. Liscouski will participate in Quantum Technology Ecosystem 1.0: A Multi-Industry Perspective on Applications (Tuesday, October 19th, from 5:15-6:45pm EDT)
    Mr. Reinhardt will take part in Technical and Organizational Aspects of Developing Applications for Early Quantum Computers (Thursday, October 21st, from 12:45-2:15pm EDT)
    This years event is virtual.
  • Attendees will have access to all sessions on-demand until the end of December 2021.
  • They will focus on potential applications of quantum technologies within the artificial intelligence, cryptography, and space & defense industries.